Symbiotec Pharmalab (SYMBIOTEC) — Insider Trading

📢 Key Event
Promoters re-created pledges over shares as security for debentures.

💡 Investor Takeaway
This filing reflects routine compliance with pledge re-creation requirements and does not indicate any change in promoter holding or financial position.

On September 11, 2026, Symbiotec Pharmalab disclosed the re-creation of pledges over 4,50,896 shares held by Anil Satwani, 3,13,938 shares by Sushil Satwani, 5,00,896 shares by Kashish Satwani, 98,19,885 shares by Satwani Holdings LLP, and 3,50,000 shares each by Kashish and Anil Satwani Family Trust and Arjun Anil Satwani Family Trust and Krishna Anil Satwani Family Trust in favor of Beacon Trusteeship Limited as security trustee for debenture collateral. The filing confirms no net change in pledged holdings, merely administrative re-creation post-lock-in completion. This is standard compliance under SEBI SAST Regulations for encumbrance disclosure.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SYMBIOTEC ✨ Ask AI About This

About Symbiotec Pharmalab Ltd (SYMBIOTEC)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹6,197.7 Cr

View full SYMBIOTEC stock details →

📡 Get AI alerts when SYMBIOTEC files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SYMBIOTEC — Free

💡 Ask AI about this filing

"What is the total promoter holding percentage after these pledges?" "How does this pledge affect the company's debt obligations?" "What is the current market price of SYMBIOTEC shares?"

Ask AI Free →

📊 More SYMBIOTEC filings

See all SYMBIOTEC filings →

🔥 Also filed on 12 September 2026

MOLBIO Molbio Diagnostics Ltd Financial Results RPEL Raghav Productivity Enhancers Ltd Announcement 544831 Meenakshi (India) Ltd Announcement KRYSTAL Krystal Integrated Services Ltd Announcement WEWORK Wework India Management Ltd Board Meeting 516038 KS Smart Technlogies Limited Related Party Transaction

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SYMBIOTEC files new disclosures

Track SYMBIOTEC filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SYMBIOTEC — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd